• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
In Reply.回复。
Oncologist. 2020 May;25(5):e876. doi: 10.1634/theoncologist.2020-0059. Epub 2020 Mar 23.
2
Sarcopenia and Inflammation with Immunotherapy.肌少症与免疫治疗相关的炎症
Oncologist. 2020 May;25(5):e875. doi: 10.1634/theoncologist.2019-1005. Epub 2020 Mar 19.
3
Perception of severity of adverse events in oral immunotherapy - Authors' reply.口服免疫疗法中不良事件严重程度的认知——作者回复
Lancet. 2020 Feb 8;395(10222):415-416. doi: 10.1016/S0140-6736(19)32567-X.
4
Reply to: "Mortality due to immunotherapy related hepatitis".
J Hepatol. 2018 Oct;69(4):978-979. doi: 10.1016/j.jhep.2018.07.009. Epub 2018 Aug 7.
5
Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?".
J Hepatol. 2018 Aug;69(2):550-551. doi: 10.1016/j.jhep.2018.04.019.
6
Nanobiologics: a real game changer for targeted immunotherapy.纳米生物制剂：靶向免疫疗法的真正变革者。
Cardiovasc Res. 2019 May 1;115(6):e52-e53. doi: 10.1093/cvr/cvz078.
7
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply.嵌合抗原受体T细胞免疫疗法总成本中的所有成本核算——回复
JAMA Oncol. 2018 Dec 1;4(12):1785-1786. doi: 10.1001/jamaoncol.2018.4657.
8
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply.免疫治疗期间超进展性疾病定义的澄清——回复
JAMA Oncol. 2021 Jan 1;7(1):137. doi: 10.1001/jamaoncol.2020.5591.
9
Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Clin Nutr. 2016 Jun;35(3):765-6. doi: 10.1016/j.clnu.2016.03.006. Epub 2016 Mar 17.
10
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.骨骼肌质量对非小细胞肺癌患者纳武利尤单抗免疫治疗的预测价值：一项“假说生成器”初步报告。
Thorac Cancer. 2019 Feb;10(2):347-351. doi: 10.1111/1759-7714.12965. Epub 2019 Jan 2.

引用本文的文献

1
Is the ECOG-PS similar to the sarcopenia status for predicting mortality in older adults with cancer? A prospective cohort study.ECOG-PS 与肌少症状态相似，可预测老年癌症患者的死亡率吗？一项前瞻性队列研究。
Support Care Cancer. 2023 Jun 2;31(6):370. doi: 10.1007/s00520-023-07845-w.

本文引用的文献

1
Sarcopenia and Inflammation with Immunotherapy.肌少症与免疫治疗相关的炎症
Oncologist. 2020 May;25(5):e875. doi: 10.1634/theoncologist.2019-1005. Epub 2020 Mar 19.
2
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.肌肉减少症与全身炎症联合对免疫治疗晚期癌症患者生存的影响。
Oncologist. 2020 Mar;25(3):e528-e535. doi: 10.1634/theoncologist.2019-0751. Epub 2019 Dec 5.

回复。

In Reply.

机构信息

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

Winship Cancer Institute of Emory University, Atlanta, Georgia, USA; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.

出版信息

Oncologist. 2020 May;25(5):e876. doi: 10.1634/theoncologist.2020-0059. Epub 2020 Mar 23.

DOI:10.1634/theoncologist.2020-0059
PMID:32201999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7216441/
Abstract

Bilen et al. respond to the letter by Köstek and Demir, agreeing that a deeper understanding of new biomarkers to evaluate immunotherapy outcome is necessary.

摘要

比伦等人回复了科斯特克和德米尔的来信，同意有必要更深入地了解新的生物标志物来评估免疫治疗的效果。